Shree Ganesh Remedies appoints Akanksha as new company secretary

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Shree Ganesh Remedies appointed Ms. Akanksha as Company Secretary effective October 4, 2026
  • Aditya Vikrambhai Patel resigned from the post on October 3, 2026, citing external career opportunities
  • New appointee holds ICSI membership A81722 and degrees in Commerce and Law
  • Neither officer holds any shares in the company
powered bylight_fuzz_icon
52581438

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Remedies Limited has appointed Ms. Akanksha as its new Company Secretary and Compliance Officer, effective October 4, 2026. This appointment follows the resignation of Aditya Vikrambhai Patel from the role, which took effect upon the close of business hours on October 3, 2026.

The Board of Directors approved these changes during a meeting held on October 3, 2026. The decision was based on the recommendation of the Nomination and Remuneration Committee. Patel cited career opportunities outside the company as the reason for his departure.

Leadership transition details

The transition ensures continuity in key managerial personnel roles as mandated by regulatory standards. The resignation and subsequent appointment were disclosed to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Role Outgoing Officer Incoming Officer Effective Date
Company Secretary & Compliance Officer Aditya Vikrambhai Patel Ms. Akanksha Oct 4, 2026
Status Resigned Appointed -

Ms. Akanksha is an Associate Member of the Institute of Company Secretaries of India (ICSI) with membership number A81722. She holds a Bachelor's degree in Commerce and a Bachelor of Laws. Her professional background includes practical experience in corporate and regulatory compliances, specifically under the Companies Act, 2013, and SEBI regulations.

Professional background of new appointee

During her internship, Akanksha gained exposure to listing compliances, Registrar of Companies filings, annual compliances, and corporate governance practices. She also assisted in various corporate actions and handled quarterly, half-yearly, and annual filings with stock exchanges. Her tenure begins with no shareholding in the company, a status shared by her predecessor.

The outgoing officer, Aditya Vikrambhai Patel, served as Key Managerial Personnel before stepping down. His resignation letter, dated October 3, 2026, requested the Board to accept his resignation and make necessary filings with concerned authorities. The Board meeting commenced at 6:00 pm and concluded at 6:30 pm on the same day.

Historical Stock Returns for Shree Ganesh Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.03%-5.61%+27.95%+29.28%+29.28%+29.28%

How will Ms. Akanksha's specific experience with SEBI regulations influence Shree Ganesh Remedies' upcoming compliance strategy?

Are there any pending regulatory filings or corporate actions that might face delays or scrutiny during this leadership transition?

Will the change in Compliance Officer lead to any observable adjustments in the company's corporate governance disclosures or internal control mechanisms?

like15
dislike

Shree Ganesh Remedies AGM passes all resolutions with 99.99% shareholder support

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Shareholders approved FY26 financials and governance changes with 99.99% support
  • Promoter group voted 100% of its 9.35 million shares across all resolutions
  • Total voting participation stood at 79.10% of outstanding equity shares
  • Ms. Hiral Shah appointed as independent director via special resolution
  • Cost auditor remuneration for FY27 ratified by M.I. Prajapati & Associates LLP
powered bylight_fuzz_icon
50757254

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Remedies shareholders overwhelmingly approved all four resolutions at its 31st Annual General Meeting on September 12, 2026. The company reported a 79.10% participation rate in the electronic voting process, with promoters casting votes on 100% of their outstanding shares.

The meeting, held via Video Conferencing or Other Audio-Visual Means, concluded at 11:58 am. Chairman and Managing Director Chandulal Manubhai Kothia chaired the session, while Whole-time Director and CFO Parth Chandulal Kothia presented the financial overview for FY26. Company Secretary Aditya Vikrambhai Patel submitted the voting results to BSE Limited pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Voting Results Overview

A total of 8,255 shareholders were on record as of September 5, 2026. Of these, 50 shareholders attended via video conferencing (7 promoters and 43 public shareholders). No shareholders were present in person or through proxy.

The voting was conducted electronically from September 9 to September 11, 2026, and during the AGM. CS Vishal Thawani of VTSN & Associates LLP served as the scrutinizer.

Resolution Votes Polled % Participation Votes In Favour % Support Status
Adopt FY26 Financials 10,154,235 79.10% 10,154,227 99.99% Passed
Reappoint C.M. Kothia 10,154,235 79.10% 10,154,227 99.99% Passed
Ratify Cost Auditors 10,036,725 78.18% 10,036,717 99.99% Passed
Appoint H. Shah as ID 10,036,725 78.18% 10,036,717 99.99% Passed

Key Resolutions Approved

Adoption of Financial Statements Shareholders approved the audited standalone and consolidated financial statements for the financial year ended March 31, 2026. This ordinary resolution received support from 100% of promoter votes and 99.99% of public non-institutional votes. Only eight votes were cast against the resolution, all from remote e-voting by public non-institutional shareholders.

Director Reappointment The meeting approved the reappointment of Mr. Chandulal Manubhai Kothia (DIN: 00652806), who retires by rotation. The promoter group, holding 9,350,529 shares, voted unanimously in favor. Public institutional shareholders also voted 100% in favor.

Cost Auditor Remuneration Shareholders ratified the remuneration payable to M/s. M.I. Prajapati & Associates LLP for the financial year ending March 31, 2027. This resolution saw slightly lower participation from public non-institutional investors (20.36%) compared to the financial statement adoption (23.84%), though support remained near-universal at 99.99%.

Independent Director Appointment The special resolution to appoint Ms. Hiral Ankitkumar Shah (DIN: 07164025) as an independent director was passed with the requisite majority. Like the cost auditor resolution, it received 100% support from promoters and institutions.

Scrutinizer’s Report

The scrutinizer confirmed that the e-voting facility was provided by Central Depository Services (India) Limited (CDSL). Votes cast via remote e-voting were blocked for those members who also voted during the AGM via VC/OAVM, ensuring no double voting. The data was unblocked and downloaded in the presence of two independent witnesses after the conclusion of the meeting.

Historical Stock Returns for Shree Ganesh Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
+1.03%-5.61%+27.95%+29.28%+29.28%+29.28%

How might the appointment of Ms. Hiral Ankitkumar Shah as an independent director influence Shree Ganesh Remedies' strategic governance and compliance oversight in the coming fiscal year?

Given the near-unanimous approval of FY26 financials, what specific growth initiatives or margin improvement strategies did CFO Parth Chandulal Kothia highlight as priorities for FY27?

With promoter participation at 100% and high overall e-voting engagement, does this shareholder alignment suggest reduced risk of activist investor challenges or proxy disputes in the near term?

like17
dislike

More News on Shree Ganesh Remedies

1 Year Returns:+29.28%